Literature DB >> 30468189

Pharmacology: Dangerous interactions.

J E Tebbutt, R M Graham.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30468189     DOI： 10.1038/sj.bdj.2018.1042

Source DB:  PubMed          Journal:  Br Dent J        ISSN： 0007-0610            Impact factor:   1.626


× No keyword cloud information.
  5 in total

1.  Statins and oral ulceration.

Authors:  D J Smith; M Dillon; J Russell; A Kanatas
Journal:  Br Dent J       Date:  2016-01-22       Impact factor: 1.626

2.  Rhabdomyolysis caused by the moderate CYP3A4 inhibitor fluconazole in a patient on stable atorvastatin therapy: a case report and literature review.

Authors:  S-H Hsiao; H-J Chang; T-H Hsieh; S-M Kao; P-Y Yeh; T-J Wu
Journal:  J Clin Pharm Ther       Date:  2016-07-19       Impact factor: 2.512

3.  Rhabdomyolysis in a patient receiving atorvastatin and fluconazole.

Authors:  Juhani Kahri; Miia Valkonen; Tom Bäcklund; Matti Vuoristo; Kari T Kivistö
Journal:  Eur J Clin Pharmacol       Date:  2004-12-30       Impact factor: 2.953

4.  [Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole].

Authors:  C C Franz; M Bruggisser; S Krähenbühl; A E Rätz Bravo
Journal:  Praxis (Bern 1994)       Date:  2011-03-02

5.  Morbidity and mortality associated with the interaction of miconazole oral gel and warfarin.

Authors:  M N Pemberton
Journal:  Br Dent J       Date:  2018-07-27       Impact factor: 1.626
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.